# Use of Topical Subgingival Application of Simvastatin Gel in the Treatment of Peri-Implant Mucositis

> **NCT03400475** · PHASE2 · COMPLETED · sponsor: **Ahmed Mohamed Mahrous** · enrollment: 46 (actual)

## Conditions studied

- Peri-implant Mucositis

## Interventions

- **DRUG:** Simvastatin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03400475
- **Lead sponsor:** Ahmed Mohamed Mahrous
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-23
- **Primary completion:** 2016-10-24
- **Final completion:** 2016-10-24
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2018-12-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03400475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03400475, "Use of Topical Subgingival Application of Simvastatin Gel in the Treatment of Peri-Implant Mucositis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03400475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*